Greenwich LifeSciences, Inc. (GLSI)

NASDAQ: GLSI · Real-Time Price · USD

15.01

+0.46 (3.16%)

Oct 19, 2026, 1:45 PM EDT - Market open

Greenwich LifeSciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	220	291	148	135	195	319
Market Cap Growth	56.48%	97.19%	9.21%	-30.79%	-38.84%	-31.08%
Enterprise Value	211	287	142	126	180	290
Last Close Price	14.55	21.01	11.23	10.52	15.20	24.33

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PB Ratio	68.52	824.09	162.46	20.17	14.78	11.90
P/TBV Ratio	68.52	824.09	162.78	20.19	14.79	11.91

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Debt / Equity Ratio	-2.85	-17.49	-4.50	-1.04	-1.02	-1.01
Net Debt / EBITDA Ratio	0.39	0.32	0.23	0.75	1.68	5.92
Quick Ratio	1.54	1.06	1.29	23.74	51.23	70.63
Current Ratio	1.54	1.06	1.29	23.74	51.23	70.63
Return on Equity (ROE)	-986.32%	-3068.25%	-457.73%	-89.30%	-39.08%	-16.78%
Return on Assets (ROA)	-235.98%	-236.67%	-198.82%	-56.95%	-24.70%	-10.28%
Return on Capital Employed (ROCE)	-726.90%	-5505.90%	-1941.10%	-139.20%	-60.80%	-17.10%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-10.52%	-6.65%	-11.80%	-6.58%	-4.01%	-1.43%
Buyback Yield / Dilution	-7.79%	-4.00%	-1.29%	0.51%	0.23%	-36.27%

SEC Filings: 10-K · 10-Q